Current Report Filing (8-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 26, 2012

 

 

 

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Florida		0-23832		59-2280364
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)
4345 Southpoint Blvd.,
Jacksonville, Florida				32216
(Address of principal executive offices)				(Zip Code)
Registrant’s telephone number, including area code				[phone]

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 8.01. Other Events.

On December 26, 2012, PSS World Medical, Inc. (the “Company”) and McKesson Corporation (“McKesson”) issued a joint press release announcing that McKesson has received notification of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with McKesson’s proposed acquisition of the Company. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit Number		Description
99.1		Joint press release dated December 26, 2012.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		PSS World Medical, Inc. (Registrant)
December 26, 2012				/s/ David M. Bronson
		By:		David M. Bronson
		Its:		Executive Vice President and Chief Financial Officer

---

EXHIBIT INDEX

 

Exhibit Number		Description
99.1		Joint press release dated December 26, 2012.